Form 4: Veracyte Director Jens Holstein Acquires and Disposes of Shares
SEC Form 4
Director Jens Holstein reports acquiring and disposing of Veracyte, Inc. common stock on June 13, 2024.
Summary
- On June 13, 2024, Jens Holstein, a director of Veracyte, Inc., engaged in transactions involving the company's common stock.
- Holstein acquired 11,473 shares of common stock.
- Concurrently, Holstein disposed of 37,878 shares of common stock.
- Following these transactions, Holstein beneficially owns 37,878 shares.
- Holstein was also awarded restricted stock units that vest on the first anniversary of the grant date or earlier under certain conditions.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It doesn't necessarily reflect a broader trend in the diagnostics industry but offers insight into an individual director's investment decisions.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 06/13/2024 | Date of stock acquisition, disposition, and restricted stock unit award. |
| 06/17/2024 | Date of report signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.